Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Interactive Online Test Helps Detect Alzheimer's Disease Early

By LabMedica International staff writers
Posted on 01 Apr 2010
A new test is more than 95% effective in detecting abnormalities associated Alzheimer's disease and other forms of cognitive impairment.

The computerized self-test (CST) is a brief, interactive online test that works to assess various impairments in functional cognitive domains. More...
It is a type of fitness test for the basic functions of thinking and processing information that are affected by Alzheimer's and milder forms of cognitive impairment.

The CST was designed to be both effective and relatively simple for medical professionals to administer and for patients to take. The impetus for the test came from data showing that 60% of Alzheimer's cases are not diagnosed in the primary care setting, and that those delays lead to missed treatment opportunities.

Rex Cannon, adjunct research assistant professor of psychology at the University of Tennessee, Knoxville (UT Knoxville; USA) and Dr. John Dougherty, associate professor at the University of Tennessee (UT) Graduate School of Medicine (Knoxville, USA), worked with a team of scientists to develop the CST.

Prof. Cannon noted that the test could provide an objective way to determine what diseases may affect the patient and provide information to begin treatments that can blunt the effects of Alzheimer's.

Related Links:

University of Tennessee, Knoxville
University of Tennessee Graduate School of Medicine




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.